ÂÜÀòÂÒÂ×

Jorge Conde is a General Partner at Andreessen Horowitz since 2017, focusing on investments at the intersection of biology, computer science, and engineering. In addition to this role, Jorge serves as a board member for multiple companies, including IDRx, Vicinitas Therapeutics, Cartography Biosciences, Tome Biosciences, Dyno Therapeutics, Komodo Health, Octant, Asimov, and CAMP4 Therapeutics. Jorge's educational background includes a Master of Business Administration from Harvard Business School, a Master of Science in the Biomedical Enterprise Program from the Massachusetts Institute of Technology, and a Bachelor of Arts in Biology from The Johns Hopkins University.